STOCK TITAN

GlycoMimetics to Report First Quarter 2024 Financial Results on May 9, 2024

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
GlycoMimetics, Inc. (GLYC) will host a conference call and webcast to report first quarter 2024 financial results on May 9, 2024. Participants can access the call by phone or webcast. A replay will be available for 30 days.
GlycoMimetics, Inc. (GLYC) ospiterà una conferenza telefonica e un webcast per rendicontare i risultati finanziari del primo trimestre del 2024 il 9 maggio 2024. I partecipanti possono accedere alla chiamata telefonicamente o tramite webcast. Una registrazione sarà disponibile per 30 giorni.
GlycoMimetics, Inc. (GLYC) organizará una llamada de conferencia y una transmisión web para informar los resultados financieros del primer trimestre de 2024 el 9 de mayo de 2024. Los participantes podrán acceder a la llamada por teléfono o a través de la transmisión web. Estará disponible una repetición durante 30 días.
글리코미멤틱스(GlycoMimetics), Inc. (GLYC)는 2024년 5월 9일에 2024년 1분기 재무 결과를 보고하기 위한 컨퍼런스 콜과 웹캐스트를 개최할 예정입니다. 참가자는 전화 또는 웹캐스트를 통해 연결할 수 있습니다. 재생은 30일 동안 사용 가능합니다.
GlycoMimetics, Inc. (GLYC) organisera une conférence téléphonique et un webcast le 9 mai 2024 pour rapporter les résultats financiers du premier trimestre de 2024. Les participants pourront accéder à l'appel par téléphone ou via webcast. Une rediffusion sera disponible pendant 30 jours.
GlycoMimetics, Inc. (GLYC) wird am 9. Mai 2024 einen Konferenzanruf und Webcast abhalten, um die Finanzergebnisse für das erste Quartal 2024 vorzustellen. Teilnehmer können sich telefonisch oder per Webcast einwählen. Eine Wiedergabe ist 30 Tage lang verfügbar.
Positive
  • None.
Negative
  • None.

ROCKVILLE, Md.--(BUSINESS WIRE)-- GlycoMimetics, Inc. (Nasdaq: GLYC), today announced that it will host a conference call and webcast to report first quarter 2024 financial results on Thursday, May 9, 2024 at 8:30 a.m. ET.

To access the call by phone, please go to this registration link and you will be provided with dial in details. Participants are encouraged to connect 15 minutes in advance of the scheduled start time.

A live webcast of the call will be available on the “Investors” tab on the GlycoMimetics website. A webcast replay will be available for 30 days following the call.

About GlycoMimetics, Inc.

GlycoMimetics is a late clinical-stage biotechnology company discovering and developing glycobiology-based therapies for cancers, including AML, and for inflammatory diseases. The company’s scientific approach is based on an understanding of the role that carbohydrates play in cell recognition. Its specialized chemistry platform is being deployed to discover small molecule drugs, known as glycomimetics, that alter carbohydrate-mediated recognition in diverse disease states, including cancers and inflammation. GlycoMimetics is leveraging its differentiated expertise with this scientific approach in order to advance its pipeline of wholly owned drug candidates. The company’s goal is to develop transformative therapies for diseases with high unmet medical need. GlycoMimetics is headquartered in Rockville, MD in the BioHealth Capital Region. Learn more at www.glycomimetics.com.

Investor Contact:

Argot Partners

Leo Vartorella

212-600-1902

Glycomimetics@argotpartners.com

Source: GlycoMimetics, Inc.

FAQ

When will GlycoMimetics report its first quarter 2024 financial results?

GlycoMimetics will report its first quarter 2024 financial results on May 9, 2024.

How can I access the conference call for GlycoMimetics first quarter 2024 financial results?

Participants can access the call by phone through a registration link provided by GlycoMimetics.

Where can I find the webcast replay of the conference call for GlycoMimetics first quarter 2024 financial results?

A webcast replay will be available on the 'Investors' tab on the GlycoMimetics website for 30 days following the call.

GlycoMimetics, Inc.

NASDAQ:GLYC

GLYC Rankings

GLYC Latest News

GLYC Stock Data

13.86M
62.47M
3.12%
47.91%
8.74%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
ROCKVILLE